Scott Schoenhaus
Stock Analyst at Keybanc
(2.07)
# 3,010
Out of 4,981 analysts
112
Total ratings
38.78%
Success rate
-4.94%
Average return
Main Sectors:
Stocks Rated by Scott Schoenhaus
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LFMD LifeMD | Maintains: Overweight | $14 → $12 | $5.80 | +106.90% | 4 | Aug 6, 2025 | |
| SLP Simulations Plus | Downgrades: Sector Weight | n/a | $15.05 | - | 5 | Jul 15, 2025 | |
| HNGE Hinge Health | Maintains: Overweight | $45 → $60 | $57.63 | +4.11% | 2 | Jul 14, 2025 | |
| EMN Eastman Chemical Company | Maintains: Overweight | $106 → $93 | $67.16 | +38.48% | 1 | Jul 14, 2025 | |
| DOCS Doximity | Maintains: Overweight | $65 → $70 | $71.03 | -1.45% | 4 | Jul 14, 2025 | |
| CERT Certara | Maintains: Overweight | $18 → $15 | $11.28 | +33.04% | 5 | Jul 14, 2025 | |
| ALB Albemarle | Maintains: Overweight | $95 → $87 | $75.98 | +14.50% | 1 | Jul 14, 2025 | |
| ABCL AbCellera Biologics | Maintains: Overweight | $5 → $10 | $4.47 | +123.71% | 6 | Jul 14, 2025 | |
| SDGR Schrödinger | Maintains: Overweight | $30 → $32 | $18.57 | +72.32% | 5 | Apr 16, 2025 | |
| PHR Phreesia | Maintains: Overweight | $30 → $28 | $24.19 | +15.75% | 7 | Apr 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $52 → $50 | $62.89 | -20.50% | 3 | Apr 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $110 → $100 | $92.49 | +8.12% | 5 | Apr 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $7 → $5 | $3.13 | +59.74% | 6 | Apr 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $5 → $9 | $2.55 | +252.94% | 6 | Apr 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $285 → $255 | $276.43 | -7.75% | 15 | Jan 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $12 → $10 | $4.83 | +107.04% | 6 | Jan 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $7 → $6 | $4.19 | +43.20% | 5 | Jan 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $4.5 | $2.56 | +75.78% | 1 | Dec 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $10 → $11 | $3.68 | +198.91% | 6 | Nov 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sector Weight | n/a | $22.51 | - | 5 | May 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sector Weight | n/a | $31.83 | - | 8 | Oct 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sector Weight | n/a | $7.68 | - | 4 | Sep 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $180 → $250 | $187.22 | +33.53% | 2 | Apr 16, 2021 |
LifeMD
Aug 6, 2025
Maintains: Overweight
Price Target: $14 → $12
Current: $5.80
Upside: +106.90%
Simulations Plus
Jul 15, 2025
Downgrades: Sector Weight
Price Target: n/a
Current: $15.05
Upside: -
Hinge Health
Jul 14, 2025
Maintains: Overweight
Price Target: $45 → $60
Current: $57.63
Upside: +4.11%
Eastman Chemical Company
Jul 14, 2025
Maintains: Overweight
Price Target: $106 → $93
Current: $67.16
Upside: +38.48%
Doximity
Jul 14, 2025
Maintains: Overweight
Price Target: $65 → $70
Current: $71.03
Upside: -1.45%
Certara
Jul 14, 2025
Maintains: Overweight
Price Target: $18 → $15
Current: $11.28
Upside: +33.04%
Albemarle
Jul 14, 2025
Maintains: Overweight
Price Target: $95 → $87
Current: $75.98
Upside: +14.50%
AbCellera Biologics
Jul 14, 2025
Maintains: Overweight
Price Target: $5 → $10
Current: $4.47
Upside: +123.71%
Schrödinger
Apr 16, 2025
Maintains: Overweight
Price Target: $30 → $32
Current: $18.57
Upside: +72.32%
Phreesia
Apr 16, 2025
Maintains: Overweight
Price Target: $30 → $28
Current: $24.19
Upside: +15.75%
Apr 16, 2025
Maintains: Overweight
Price Target: $52 → $50
Current: $62.89
Upside: -20.50%
Apr 16, 2025
Maintains: Overweight
Price Target: $110 → $100
Current: $92.49
Upside: +8.12%
Apr 16, 2025
Maintains: Overweight
Price Target: $7 → $5
Current: $3.13
Upside: +59.74%
Apr 16, 2025
Maintains: Overweight
Price Target: $5 → $9
Current: $2.55
Upside: +252.94%
Jan 8, 2025
Maintains: Overweight
Price Target: $285 → $255
Current: $276.43
Upside: -7.75%
Jan 8, 2025
Maintains: Overweight
Price Target: $12 → $10
Current: $4.83
Upside: +107.04%
Jan 8, 2025
Maintains: Overweight
Price Target: $7 → $6
Current: $4.19
Upside: +43.20%
Dec 9, 2024
Initiates: Overweight
Price Target: $4.5
Current: $2.56
Upside: +75.78%
Nov 13, 2024
Maintains: Overweight
Price Target: $10 → $11
Current: $3.68
Upside: +198.91%
May 10, 2024
Downgrades: Sector Weight
Price Target: n/a
Current: $22.51
Upside: -
Oct 11, 2023
Downgrades: Sector Weight
Price Target: n/a
Current: $31.83
Upside: -
Sep 16, 2022
Initiates: Sector Weight
Price Target: n/a
Current: $7.68
Upside: -
Apr 16, 2021
Upgrades: Overweight
Price Target: $180 → $250
Current: $187.22
Upside: +33.53%